Pancreatic Cancer Research

ResearcherYale Cancer CenterNo recent work listed

Lingeng Lu

Matched on ORCID iD 0000-0001-9871-0809; OpenAlex author ID A5101569049. Sources: OpenAlex.

Their work

Papers
15 (first author 4, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
26
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: 1 paper · 2015: 5 papers · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: 2 papers · 2020: 1 paper · 2021: 1 paper

Papers 15

  1. A Circulating Exosome RNA Signature Is a Potential Diagnostic Marker for Pancreatic Cancer, a Systematic Study. Last author DOI 10.3390/cancers13112565↗
  2. Syndecan-1 and KRAS Gene Expression Signature Associates With Patient Survival in Pancreatic Cancer. Last author DOI 10.1097/mpa.0000000000001654↗
  3. Current Approaches to Pancreatic Cancer Screening. First author DOI 10.1016/j.ajpath.2018.09.013↗
  4. Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer. Co-author DOI 10.1093/jnci/djy155↗
  5. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Co-author DOI 10.1038/s41467-018-02942-5↗
  6. Aspirin Use and Reduced Risk of Pancreatic Cancer. First author DOI 10.1158/1055-9965.epi-16-0508↗
  7. Exosomes: potential for early detection in pancreatic cancer. Co-author DOI 10.2217/fon-2015-0005↗
  8. Plasma metabolite biomarkers for the detection of pancreatic cancer. First author DOI 10.1021/pr501135f↗
  9. Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. Co-author DOI 10.1038/ng.3341↗
  10. Risch et al. Respond to "Clinical Utility of Prediction Models for Rare Outcomes: The Example of Pancreatic Cancer". Co-author DOI 10.1093/aje/kwv025↗
  11. Detectable Symptomatology Preceding the Diagnosis of Pancreatic Cancer and Absolute Risk of Pancreatic Cancer Diagnosis. Co-author DOI 10.1093/aje/kwv026↗
  12. Vitamin D and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium. Co-author DOI 10.1093/annonc/mdv236↗
  13. Case-control study of aspirin use and risk of pancreatic cancer. Co-author DOI 10.1158/1055-9965.epi-13-1284↗
  14. ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis. First author DOI 10.1093/aje/kws458↗
  15. Genetic effects and modifiers of radiotherapy and chemotherapy on survival in pancreatic cancer. Co-author DOI 10.1097/mpa.0b013e31821268d1↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Harvey A. Risch · 10 shared papers, 2011–2019 · strength 0.67
  2. Herbert Yu · 8 shared papers, 2011–2017 · strength 0.42
  3. Béatrice Fervers · 2 shared papers, 2020–2021 · strength 0.31
  4. Yixing Wu · 2 shared papers, 2020–2021 · strength 0.31
  5. Mark S. Kidd · 5 shared papers, 2011–2017 · strength 0.30
  6. Hongmei Zeng · 2 shared papers, 2011–2021 · strength 0.17
  7. Yu-Tang Gao · 3 shared papers, 2013–2017 · strength 0.16
  8. Quanxing Ni · 3 shared papers, 2013–2017 · strength 0.16
  9. Samantha A. Streicher · 2 shared papers, 2014–2017 · strength 0.12
  10. Ankit Chhoda · 1 shared paper, 2019 · strength 0.12
  11. James J. Farrell · 1 shared paper, 2019 · strength 0.12
  12. Guoxiang Xie · 1 shared paper, 2015 · strength 0.05
  13. Wei Ping Jia · 1 shared paper, 2015 · strength 0.05
  14. H. Bas Bueno-de-Mesquita · 1 shared paper, 2015 · strength 0.04
  15. Rachel Ε. Neale · 1 shared paper, 2015 · strength 0.04
  16. Halcyon G. Skinner · 1 shared paper, 2015 · strength 0.04
  17. Kristin E. Anderson · 1 shared paper, 2015 · strength 0.04
  18. Sean Patrick Cleary · 1 shared paper, 2015 · strength 0.04
  19. Patrick Maisonneuve · 1 shared paper, 2015 · strength 0.04
  20. Cristina Bosetti · 1 shared paper, 2015 · strength 0.04
  21. Michelle Cotterchio · 1 shared paper, 2015 · strength 0.04
  22. Mary A. Waterhouse · 1 shared paper, 2015 · strength 0.04
  23. Paige M. Bracci · 1 shared paper, 2015 · strength 0.04
  24. Gloria M. Petersen · 1 shared paper, 2015 · strength 0.04
  25. Carlo La Vecchia · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.